Care of the Pediatric Cardiac Surgery Patient-Part 1

Current Problems in Surgery

Volumn 47, Issue 3, 2010, Pages 185-250

  Gazit, Avihu Z ^a   Huddleston, Charles B ^a   Checchia, Paul A ^a   Fehr, James ^a   Pezzella, A Thomas ^b  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CORTICOSTEROID; MILRINONE; TRANEXAMIC ACID;

ANALGESIA; AORTA COARCTATION; AORTA SUPRAVALVULAR STENOSIS; ARTICLE; BLOOD CLOTTING DISORDER; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CARDIOVASCULAR DISEASE; CHILD CARE; CHILDHOOD MORTALITY; CLINICAL FEATURE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL HEART DISEASE; CONGESTIVE CARDIOMYOPATHY; CONSERVATIVE TREATMENT; CONTRAST ENHANCEMENT; CORONARY ARTERY BLOOD FLOW; DIAGNOSTIC TEST; DISEASE CONTROL; DISEASE COURSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; GENOTYPE PHENOTYPE CORRELATION; HEART ARRHYTHMIA; HEART CATHETERIZATION; HEART DISEASE; HEART HEMODYNAMICS; HEART SURGERY; HISTORY OF MEDICINE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INCIDENCE; INTENSIVE CARE; LABORATORY TEST; LUNG BLOOD VESSEL; MAGNETIC RESONANCE ANGIOGRAPHY; MARFAN SYNDROME; MODIFIED ULTRAFILTRATION; MYOCARDIAL DISEASE; NEUROMUSCULAR BLOCKING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATENT DUCTUS ARTERIOSUS; PATHOPHYSIOLOGY; PATIENT SAFETY; PEDIATRIC ANESTHESIA; PEDIATRIC SURGERY; PERIOPERATIVE PERIOD; PEROPERATIVE CARE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PREVALENCE; PULMONARY HYPERTENSION; PULMONARY VEIN MALFORMATION; RESTRICTIVE CARDIOMYOPATHY; SEDATION; STENT; SURGICAL APPROACH; SURGICAL RISK; SURGICAL TECHNIQUE; SYSTEMIC PULMONARY SHUNT; SYSTEMIC VASCULAR RESISTANCE; THORAX RADIOGRAPHY; THREE DIMENSIONAL IMAGING; TISSUE DOPPLER IMAGING; WILLIAMS BEUREN SYNDROME;

CARDIAC SURGICAL PROCEDURES; CHILD; HEART DISEASES; HUMANS; INTENSIVE CARE UNITS, PEDIATRIC; POSTOPERATIVE CARE; PREOPERATIVE CARE;

EID: 77649194635     PISSN: 00113840     EISSN: None     Source Type: Journal    
DOI: 10.1067/j.cpsurg.2009.11.006     Document Type: Article

References (290)

1. Calvin J.E., Habet K., Parillo J.E. Critical care in the United States. Who are we and how did we get here?. Crit Care Clin 1997, 1E3:363-376.
2. Todres I.D. History of pediatric critical care. Pediatric Critical Care 2006, 7-14. Mosby, Elsevier, Philadelphia, PA. B.P. Fuhrman, J.J. Zimmerman (Eds.).
3. Parker M.M., Brilli R.J., Culver K. Multidisciplinary critical care and the role of the subspecialist in the pediatric intensive care unit. Pediatric Critical Care 2006, 3-6. Mosby, Elsevier, Philadelphia, PA. B.P. Fuhrman, J.J. Zimmerman (Eds.).
4. Friedman W.F., Silverman N. Congenital heart disease in infancy and childhood. Heart Disease 2001, 1505-1591. WB Saunders, Philadelphia, PA. E. Braunwald, D.P. Zipes, P. Libby (Eds.).
5. Hoffman J.I.E. Incidence, prevalence, and inheritance of congenital heart disease. Pediatric Cardiovascular Medicine 2000, 257-262. Churchill Livingstone, New York, NY. J.H. Moller, J.I. Hoffman (Eds.).
6. Schultz A.H., Localio A.R., Clark B.J., Ravishankar C., Videon N., Kimmel S.E. Epidemiological features of the presentation of critical congenital heart disease: implications for screening. Pediatrics 2008, 121:751-757.
7. Martin J.A., Kung H.C., Mathews T.J., Hoyert D.L., Strobino D.M., Guyer B. Annual summary of vital statistics. Pediatrics 2008, 121:788-801.
8. Boneva R.S., Botto L.D., Moore C.A., Yang Q., Correa A., Erickson J.D. Mortality associated with congenital heart defects in the United States: trends and racial disparities, 1979-97. Circulation 2001, 103:2376-2381.
9. Tchervenko CI. Hearts for life across the world. In: Presidential Address First Meeting World Society for Pediatric and Congenital Heart Surgery, Washington, DC, May 4, 2007.
10. Campbell M. Incidence of cardiac malformations at birth and later, and neonatal mortality. Br Heart J 1973, 35:189-200.
11. Campbell M. Natural history of persistent ductus arteriosus. Br Heart J 1968, 30:4-13.
12. Hoffman J.I.E., Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002, 39:1890-1900.
13. Hoffman J.I.E., Kaplan S., Liberthson R.R. Prevalence of congenital heart disease. Am Heart J 2004, 147:425-439.
14. Bull C. Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK. Lancet 1999, 354:1242-1247. British Paediatric Cardiac Association.
15. Tworetzky W., McElhinney D.B., Reddy V.M., Brook M.M., Hanley F.L., Silverman N.H. Improved surgical outcome after fetal diagnosis of hypoplastic left heart syndrome. Circulation 2001, 103:1269-1273.
16. Nora J.J. Multifactorial inheritance hypothesis for the etiology of congenital heart disease. The genetic-environmental interaction. Circulation 1968, 38:604-617.
17. Boudjemline Y., Fermont L., Le Bidois J., Lyonnet S., Sidi D., Bonnet D. Prevalence of 22q11 deletion in fetuses with conotruncal cardiac defects: a 6-year prospective study. J Pediatr 2001, 138:520-524.
18. Heymann M.A., Rudolph A.M. Effects of congenital heart disease on fetal and neonatal circulations. Prog Cardiovasc Dis 1972, 15:115-143.
19. Auman H.J., Coleman H., Riley H.E., Olale F., Tsai H.J., Yelon D. Functional modulation of cardiac form through regionally confined cell shape changes. PLoS Biol 2007, 5:604-615.
20. Yashiro K., Shiratori H., Hamada H. Haemodynamics determined by a genetic programme govern asymmetric development of the aortic arch. Nature 2007, 450:285-288.
21. Boudjemline Y., Fermont L., Le Bidois J., Villain E., Sidi D., Bonnet D. Can we predict 22q11 status of fetuses with tetralogy of Fallot?. Prenat Diagn 2002, 22:231-234.
22. Kamath B.M., Spinner N.B., Emerick K.M., Chudley A.E., Booth C., Piccoli D.A., et al. Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality. Circulation 2004, 109:1354-1358.
23. Buckingham M., Meilhac S., Zaffran S. Building the mammalian heart from two sources of myocardial cells. Nat Rev Genet 2005, 6:826-835.
24. Bruneau B.G. The developmental genetics of congenital heart disease. Nature 2008, 451:943-948. [review].
25. Olson E.N. Gene regulatory networks in the evolution and development of the heart. Science 2006, 13:1922-1927.
26. Srivastava D. Making or breaking the heart: from lineage determination to morphogenesis [review]. Cell 2006, 126:1037-1048.
27. Formigari R., Michielon G., Digilio M.C., Piacentini G., Carotti A., Giardini A., et al. Genetic syndromes and congenital heart defects: how is surgical management affected. Eur J Cardio Thorac Surg 2009, 35:606-614.
28. Bernstein D. Cardiac development. Nelson Textbook of Pediatrics 2004, 1475-1478. WB Saunders, Philadelphia, PA. R.E. Behrman, R.E. Kliegman, H.B. Jenson (Eds.).
29. Wessels A., Sedmera D. Developmental anatomy of the heart: a tale of mice and men. Physiol Genomics 2003, 15:165-176.
30. Emmanouilides G.C. The development of pediatric cardiology. Moss and Adams Heart Disease in Infants, Children, and Adolescents 1995, Williams and Wilkins, Baltimore, MD, XXI-IV. G.C. Emmanouilides, T.A. Reimenschneider, H.D. Allen (Eds.).
31. VanPraagh R. Nomenclature and classification: morphologic and segmental approach to diagnosis. Pediatric Cardiovascular Medicine 2000, 275-288. Churchill Livingstone, New York, NY. J.H. Moller, J.I.E. Hoffman (Eds.).
32. Anderson R.H., Cook A.C. The anatomy of congenital cardiac malformations. Johns Hopkins Manual of Cardiothoracic Surgery 2007, 1001-1018. McGraw-Hill Medical, New York, NY. D.D. Yuh, L.A. Vricella, W.A. Baumgartner (Eds.).
33. Anderson R.H. Nomenclature and classification: sequential segmental analysis. Pediatric Cardiovascular Medicine 2000, 263-274. Churchill Livingstone, New York, NY. J.H. Moller, J.I. Hoffman (Eds.).
34. Weinberg P.M. Anatomy and classification of congenital heart disease. Mastery of Cardiothoracic Surgery 2007, 639-650. Lippincott Williams & Wilkins, Philadelphia, PA. L.R. Kaiser, I.L. Kron, T.L. Spray (Eds.).
35. Kouchoukos N.T., Blackstone E.H., Doty D.B., Hanley F.L., Karp R.B. Anatomy, dimensions, and terminology. Kirklin/Barratt-Boyes Cardiac Surgery 2003, 3-65. Churchill Livingstone, Philadelphia, PA.
36. Nakata S., Imai Y., Takanashi Y., Kurosawa H., Tezuka K., Nakazawa M. A new method for the quantitative standardization of cross-sectional areas of the pulmonary arteries in congenital heart diseases with decreased pulmonary blood flow. J Thorac Cardiovasc Surg 1984, 88:610-619.
37. Chen B.B., Chen S.J., Wu M.H., Li Y.W., Lue H.C. EBCT-McGoon ratio. A reliable and useful method to predict pulmonary blood flow non-invasively. Chin J Radiol 2007, 31:1-8.
38. Mavroudis C., Bove E.L., Cameron D.E., Drinkwater D.C., Edwards F.H., Hammon J.W., et al. The Society of Thoracic Surgeons' national congenital heart surgery database. Ann Thorac Surg 1995, 59:554-556.
39. Mavroudis C., Jacobs J.P. International congenital heart surgery nomenclature and database project. Ann Thorac Surg 2000, 69(Suppl 1):1-372. eds.
40. Jacobs J.P. Nomenclature and classification for congenital cardiac surgery. Pediatric Cardiac Surgery 2003, 25-38. Mosby, Philadelphia, PA. 3rd ed. C. Mavroudis, C.L. Backer (Eds.).
41. Klein M.D., Reynolds E.M. Developmental physiology of the premature and term newborn. Operative Pediatric Surgery 2003, 37-53. McGraw-Hill Professional, New York, NY. M.M. Ziegler, R.G. Azizkhan, T.R. Weber (Eds.).
42. Rudolph A. The fetal circulation ands its adjustments after birth. Pediatric Cardiovascular Medicine 2000, 60-64. Churchill Livingstone, New York, NY. J.H. Moller, J.I.E. Hoffman (Eds.).
43. Castaneda A.R., Jonas R.A., Mayer J.E., Hanley F.L. Cardiac Surgery of the Neonate and Infant 1994, WB Saunders, Philadelphia, PA.
44. Suga H. Cardiac function. Pediatric Cardiovascular Medicine 2000, 65-77. Churchill Livingstone, New York, NY. J.H. Moller, J.I.E. Hoffman (Eds.).
45. Chowdhury D. Pathophysiology of congenital heart diseases. Ann Card Anaesth 2007, 10:19-26. [review].
46. Cassorla L. Preoperative evaluation and preparation: a physiological approach. Anesthesia for Congenital Heart Disease 2005, 175-196. Blackwell, Futura, Malden, MA. D.B. Andropoulis, S.A. Stayer, I.A. Russell (Eds.).
47. Odegard K.C., Laussen P.C. Approach to the premature and full term infant. Anesthesia for Congenital Heart Disease 2005, 197-209. Blackwell, Futura, Malden, MA. D.B. Andropoulis, S.A. Stayer, I.A. Russell (Eds.).
48. Baum V.C., Stayer S.A., Andropoulos D.B., Russell I.A. Approach to the teenaged and adult patient. Anesthesia for Congenital Heart Disease 2005, 210-222. Blackwell, Futura, Malden, MA. D.B. Andropoulis, S.A. Stayer, I.A. Russell (Eds.).
49. Chang R.R., Klitzner T.S. Resources, use, and regionalization of pediatric cardiac services. Curr Opin Cardiol 2003, 18:98-101.
50. Section on cardiology and cardiac surgery. Guidelines for pediatric cardiovascular centers. Pediatrics 2002, 109:544-549. American Academy of Pediatricians.
51. Jacobs M.L., Mavroudis C., Jacobs J.P., Tchervenkov C.I., Pelletier G.J. Report of the 2005 STS congenital heart surgery practice and manpower survey. Ann Thorac Surg 2006, 82:1152-1159.
52. Laussen P.C. Pediatric cardiac intensive care. Comprehensive Surgical Management of Congenital Heart Disease 2004, 65-115. Arnold, London, United Kingdom. R.A. Jonas (Ed.).
53. Shumacker H.B. The Evolution of Cardiac Surgery 1992, Indiana University Press, Bloomington, IN.
54. Westaby W. Landmarks in Cardiac Surgery 1997, Isis Medical Media, Oxford, United Kingdom.
55. Hurt R. The History of Cardiothoracic Surgery from Early Times 1996, Parthenon Publishing, New York, NY.
56. Vricella L.A., Gott V.L., Cameron D.E. Milestones in congenital cardiac surgery. Johns Hopkins Manual of Cardiothoracic Surgery 2007, 989-1000. McGraw-Hill Medical, New York, NY. D.D. Yuh, L.A. Vricella, W.A. Baumgartner (Eds.).
57. Williams J.A., Bansal A.K., Kim B.J., Nwakanma L.U., Patel N.D., Seth A.K., et al. Two thousand Blalock-Taussig shunts: a six-decade experience. Ann Thorac Surg 2007, 84:2070-2075. discussion 2070-5.
58. Rao P.S. Interventional pediatric cardiology: state of the art and future directions. Pediatr Cardiol 1998, 19:107-124.
59. Barach P., Johnson J.K., Ahmad A., Galvan C., Bognar A., Duncan R., et al. A prospective observational study of human factors, adverse events, and patient outcomes in surgery for pediatric cardiac disease. J Thorac Cardiovasc Surg 2008, 136:1422-1428.
60. Welke K.F., Shen I., Ungerleider R.M. Current assessment of mortality rates in congenital cardiac surgery. Ann Thorac Surg 2006, 82:164-170. discussion 170-1.
61. Welke K.F., Diggs B.S., Karamlou T., Ungerleider R.M. Comparison of pediatric cardiac surgical mortality rates from national administrative data to contemporary clinical standards. Ann Thorac Surg 2009, 87:216-222. discussion 222-3.
62. O'Brien S.M., Jacobs J.P., Clarke D.R., Maruszewski B., Jacobs M.L., Walters H.L., et al. Accuracy of the Aristotle basic complexity score for classifying the mortality and morbidity potential of congenital heart surgery operations. Ann Thorac Surg 2007, 84:2027-2037. discussion 2027-37.
63. Jenkins K.J., Gauvreau K., Newburger J.W., Spray T.L., Moller J.H., Iezzoni L.I. Consensus-based method for risk adjustment for surgery for congenital heart disease [review]. J Thorac Cardiovasc Surg 2002, 123:110-118.
64. Jacobs J.P., Mavroudis C., Jacobs M.L., Maruszewski B., Tchervenkov C.I., Lacour-Gayet F.G., et al. What is operative mortality: defining death in a surgical registry database: a report of the STS congenital database taskforce and the joint EACTS-STS congenital database committee. Ann Thorac Surg 2006, 81:1937-1941.
65. Miyamoto T., Sinzobahamvya N., Photiadis J., Brecher A.M., Asfour B. Survival after surgery with cardiopulmonary bypass in low weight patients. Asian Cardiovasc Thorac Ann 2008, 16:115-119.
66. Ades A., Johnson B.A., Berger S. Management of low birth weight infants with congenital heart disease. Clin Perinatol 2005, 32:999-1015. [review], x-xi.
67. Abrishamchian R., Kanhai D., Zwets E., Nie L., Cardarelli M. Low birth weight or diagnosis, which is a higher risk?. A meta-analysis of observational studies. Eur J Cardio Thorac Surg 2006, 30:700-705.
68. Oppido G., Napoleone C.P., Formigari R., Gabbieri D., Pacini D., Frascaroli G., et al. Outcome of cardiac surgery in low birth weight and premature infants. Eur J Cardio Thorac Surg 2004, 26:44-53.
69. Burke R.P., Hannan R.L. Reducing the trauma of congenital heart surgery. Surg Clin North Am 2000, 80:1593-1605.
70. To Err is Human: Building a Safer Health System 2000, National Academy Press, Washington, DC. L.T. Kohn, J.M. Corrigan, M.S. Donaldson (Eds.).
71. Wong D.R., Ali I.S., Torchiana D.F., Agnihotri A.K., Bohmer R.J., Vander Salm T.J. Learning in a new cardiac surgery center: an analysis of precursor events. Surgery 2009, 145:131-137.
72. Fabri P.J., Zayas-Castro J.L. Human error, not communication and systems, underlies surgical complications. Surgery 2008, 144:557-563. discussion 563-5.
73. ElBardissi A.W., Weigmann D.A., Dearani J.A., Daly R.C., Sundt T.M. Application of the human factors analysis and classification system methodology to the cardiovascular surgery operating room. Ann Thorac Surg 2007, 83:1412-1418. discussion 1418-9.
74. de Leval M.R. Beyond flatland. J Thorac Cardiovasc Surg 2003, 125:12-19.
75. Stark J.F., Stark J. Performance measurement in congenital heart surgery: benefits and drawbacks. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2003, 6:171-183.
76. Carthey J., de Leval M.R., Reason J.T. The human factor in cardiac surgery: errors and near misses in a high technology medical domain. Ann Thorac Surg 2001, 72:300-305.
77. Reason J. Human Error 1990, Cambridge University Press, New York, NY.
78. de Leval M.R., Carthey J., Wright D.J., Farewell V.T., Reason J.T. Human factors and cardiac surgery: a multicenter study. J Thorac Cardiovasc Surg 2000, 119(4 Pt. 1):661-672.
79. Edmunds L.H., Clark R.E., Cohn L.H., Grunkemeier G.L., Miller D.C., Weisel R.D. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 1996, 62:932-935.
80. Brousseau T., Sharieff G.Q. Newborn emergencies: the first 30 days of life. Pediatr Clin North Am 2006, 53:69-84. [review], vi.
81. Jaquiss R.D.B., Tweddell J.S. The neonate with congenital heart disease: what the cardiac surgeon needs to know from the neonatologist and the cardiologist. Clin Perinatol 2005, 32:947-961. ix.
82. Chin C. The cardiovascular history and physical examination. Congenital Cardiac Surgery 2002, 3-7. McGraw-Hill Inc, New York, NY, DD Y. B.A. Reitz (Ed.).
83. Ogden C.L., Kuczmarski R.J., Flegal K.M., Mei Z., Guo S., Wei R., et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002, 109:45-60.
84. Myrelid A., Gustafsson J., Ollars B., Annerén G. Growth charts for down's syndrome from birth to 18 years of age. Arch Dis Child 2002, 87:97-103.
85. Khariwala S.S., Lee W.T., Koltai P.J. Laryngotracheal consequences of pediatric cardiac surgery. Arch Otolaryngol Head Neck Surg 2005, 131:336-339.
86. Tempe D.K., Virmani S. Coagulation abnormalities in patients with cyanotic congenital heart disease. J Cardiothorac Vasc Anesth 2002, 16:752-765.
87. Momma K. Approach to the cyanotic neonate. Pediatric Cardiovascular Medicine 2000, 249-254. Churchill Livingstone, New York, NY. J.H. Moller, J.I.E. Hoffman (Eds.).
88. Lema G., Vogel A., Canessa R., Jalil R., Carvajal C., Becker P., et al. Renal function and cardiopulmonary bypass in pediatric cardiac surgical patients. Pediatr Nephrol 2006, 21:1446-1451.
89. Kang N., de Leval M.R., Elliott M., Tsang V., Kocyildirim E., Sehic I., et al. Extending the boundaries of the primary arterial switch operation in patients with transposition of the great arteries and intact ventricular septum. Circulation 2004, 110(11 suppl 1):II123-II127.
90. Hlavacek A.M., Crawford F.A., Chessa K.S., Shirali G.S. Real time three-dimensional echocardiography in congenital heart disease: a continuum of unfulfilled promises?. No. A presently clinically applicable technology with an important future? Yes. Pediatr Cardiol 2002, 23:266-285.
91. Cheng T.O., Xie M.X., Wang X.F., Wang Y., Lu Q. Real-time 3-dimensional echocardiography in assessing atrial and ventricular septal defects: an echocardiographic-surgical correlative study. Am Heart J 2004, 148:1091-1095.
92. Sadagopan S.N., Veldtman G.R., Sivaprakasam M.C., Keeton B.R., Gnanapragasam J.P., Salmon A.P., et al. Correlations with operative anatomy of real time three-dimensional echocardiographic imaging of congenital aortic valvar stenosis. Cardiol Young 2006, 16:490-494.
93. Anwar A.M., Soliman O., van den Bosch A.E., McGhie J.S., Geleijnse M.L., ten Cate F.J., et al. Assessment of pulmonary valve and right ventricular outflow tract with real-time three-dimensional echocardiography. Int J Cardiovasc Imaging 2007, 23:167-175.
94. van den Bosch A.E., Robbers-Visser D., Krenning B.J., Voormolen M.M., McGhie J.S., Helbing W.A., et al. Comparison of real-time three-dimensional echocardiography to magnetic resonance imaging for assessment of left ventricular mass. Am J Cardiol 2006, 97:113-117.
95. van den Bosch A.E., Robbers-Visser D., Krenning B.J., McGhie J.S., Helbing W.A., Meijboom F.J., et al. Real-time transthoracic three-dimensional echocardiographic assessment of left ventricular volume and ejection fraction in congenital heart disease. J Am Soc Echocardiogr 2006, 19:1-6.
96. Vassalos A., Lilley S., Young D., Peng E., MacArthur K., Pollock J., et al. Tissue Doppler imaging following paediatric cardiac surgery: early patterns of change and relationship to outcome. Interact Cardiovasc Thorac Surg 2009, 9:173-177.
97. Jone P.N., Schowengerdt K.O. Prenatal diagnosis of congenital heart disease. Pediatr Clin North Am 2009, 56:709-715.
98. Kovalchin J.P., Silverman N.H. The impact of fetal echocardiography. Pediatr Cardiol 2004, 25:299-306.
99. Yoo S.J., Lee Y.H., Cho K.S., Kim D.Y. Sequential segmental approach to fetal congenital heart disease. Cardiol Young 1999, 9:430-444. [review].
100. Allan L.D. Cardiac anatomy screening: what is the best time for screening in pregnancy?. Curr Opin Obset Gyneol 2003, 15:143-146.
101. Becker R., Wegner R.D. Detailed screening for fetal anomalies and cardiac defects at the 11-13-week scan. Ultrasound Obstet Gynecol 2006, 27:613-618.
102. Westin M., Saltvedt S., Bergman G., Kublickas M., Almström H., Grunewald C., et al. Routine ultrasound examination at 12 or 18 gestational weeks for prenatal detection of major congenital heart malformations?. A randomised controlled trial comprising 36,299 fetuses. BJOG 2006, 113:675-682.
103. Lurie I.W., Ferencz C., Brenner I.J. Heart disease in infancy: a window to the world of fetal cardiology. Prog Pediatr Cardiol 1996, 5:73-78.
104. Bonnet D., Coltri A., Butera G., Fermont L., Le Bidois J., Kachaner J., et al. Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. Circulation 1999, 99:916-918.
105. Mahle W.T., Clancy R.R., McGaurn S.P., Goin J.E., Clark B.J. Impact of prenatal diagnosis on survival and early neurologic morbidity in neonates with the hypoplastic left heart syndrome. Pediatrics 2001, 107:1277-1282.
106. Buchel E.R.V., DiBernardo S., Bauersfeld U., Berger F. Contrast-enhanced magnetic resonance angiography of the great arteries in patients with congenital heart disease: an accurate tool for planning catheter-guided interventions. Int J Cardiovasc Imaging 2005, 21:313-322.
107. Muthurangu V., Taylor A.M., Hegde S.R., Johnson R., Tulloh R., Simpson J.M., et al. Cardiac magnetic resonance imaging after stage I Norwood operation for hypoplastic left heart syndrome. Circulation 2005, 112:3256-3263.
108. Sorensen T.S., Körperich H., Greil G.F., Eichhorn J., Barth P., Meyer H., et al. Operator-independent isotropic three-dimensional magnetic resonance imaging for morphology in congenital heart disease: a validation study. Circulation 2004, 110:163-169.
109. Prasad S.K., Soukias N., Hornung T., Khan M., Pennell D.J., Gatzoulis M.A., et al. Role of magnetic resonance angiography in the diagnosis of major aortopulmonary collateral arteries and partial anomalous pulmonary venous drainage. Circulation 2004, 109:207-214.
110. Geva T., Greil G.F., Marshall A.C., Landzberg M., Powell A.J. Gadolinium-enhanced 3-dimensional magnetic resonance angiography of pulmonary blood supply in patients with complex pulmonary stenosis or atresia: comparison with X-ray angiography. Circulation 2002, 106:473-478.
111. Fratz S., Hess J., Schwaiger M., Martinoff S., Stern H.C. More accurate quantification of pulmonary blood flow by magnetic resonance imaging than by lung perfusion scintigraphy in patients with fontan circulation. Circulation 2002, 106:1510-1513.
112. Hong Y.K., Park Y.W., Ryu S.J., Won J.W., Choi J.Y., Sul J.H., et al. Efficacy of MRI in complicated congenital heart disease with visceral heterotaxy syndrome. J Comput Assist Tomogr 2000, 24:671-682.
113. Greil G.F., Powell A.J., Gildein H.P., Geva T. Gadolinium-enhanced three-dimensional magnetic resonance angiography of pulmonary and systemic venous anomalies. J Am Coll Cardiol 2002, 39:335-341.
114. Beekman R.P., Hoorntje T.M., Beek F.J., Kuijten R.H. Sedation for children undergoing magnetic resonance imaging: efficacy and safety of rectal thiopental. Eur J Pediatr 1996, 155:820-822.
115. Malviya S., Voepel-Lewis T., Eldevik O.P., Rockwell D.T., Wong J.H., Tait A.R. Sedation and general anaesthesia in children undergoing MRI and CT: adverse events and outcomes. Br J Anaesth 2000, 84:743-748.
116. Malviya S., Voepel-Lewis T., Prochaska G., Tait A.R. Prolonged recovery and delayed side effects of sedation for diagnostic imaging studies in children. Pediatrics 2000, 105:E42.
117. Mason K.P., Zurakowski D., Connor L., Karian V.E., Fontaine P.J., Sanborn P.A., et al. Infant sedation for MR imaging and CT: oral versus intravenous pentobarbital. Radiology 2004, 233:723-728.
118. Merola C., Albarracin C., Lebowitz P., Bienkowski R.S., Barst S.M. An audit of adverse events in children sedated with chloral hydrate or propofol during imaging studies. Paediatr Anaesth 1995, 5:375-378.
119. Dorfman A.L., Odegard K.C., Powell A.J., Laussen P.C., Geva T. Risk factors for adverse events during cardiovascular magnetic resonance in congenital heart disease. J Cardiovasc Magn Reson 2007, 9:793-798.
120. Oosterhof T., van Straten A., Vliegen H.W., Meijboom F.J., van Dijk A.P., Spijkerboer A.M. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation 2007, 116:545-551.
121. Therrien J., Provost Y., Merchant N., Williams W., Colman J., Webb G. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol 2005, 95:779-782.
122. Buechel E.R.V., Dave H.H., Kellenberger C.J., Dodge-Khatami A., Pretre R., Berger F., et al. Remodeling of the right ventricle after early pulmonary valve replacement in children with repaired tetralogy of Fallot: assessment by cardiovascular magnetic resonance. Eur Heart J 2005, 26:2721-2727.
123. Kim R.J., Fieno D.S., Parrish T.B., Harris K., Chen E.L., Simonetti O., et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct size, and contractile function. Circulation 1999, 100:1992-2002.
124. Babu-Narayan S.V., Kilner P.J., Li W., Moon J.C., Goktekin O., Davlouros P.A., et al. Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of Fallot and its relationship to adverse markers of clinical outcome. Circulation 2006, 113:405-413.
125. Babu-Narayan S.V., Goktekin O., Moon J.C., Broberg C.S., Pantely G.A., Pennell D.J., et al. Late gadolinium enhancement cardiovascular magnetic resonance of the systemic right ventricle in adults with previous atrial redirection surgery for transposition of the great arteries. Circulation 2005, 11:2091-2098.
126. Giardini A., Lovato L., Danti A., Formigari R., Oppido G., Gargiulo G., et al. Relation between right ventricular structural alterations and markers of adverse clinical outcome in adults with systemic right ventricle and either congenital complete (after Senning operation), or congenitally corrected transposition of the great arteries. Am J Cardiol 2006, 98:1277-1282.
127. Kondo C., Takada K., Yokoyama U., Nakajima Y., Momma K., Sakai F. Comparison of three-dimensional contrast-enhanced magnetic resonance angiography and axial radiographic angiography for diagnosing congenital stenoses in small pulmonary arteries. Am J Cardiol 2001, 87:420-424.
128. Silverman J.M., Julien P.J., Herfkens R.J., Pelc N.J. Quantitative differential pulmonary perfusion: MR imaging versus radionuclide lung scanning. Radiology 1993, 189:699-701.
129. Fratz S., Hess J., Schwaiger M., Martinoff S., Stern H.C. More accurate quantification of pulmonary blood flow by magnetic resonance imaging than by lung perfusion scintigraphy in patients with fontan circulation. Circulation 2002, 106:1510-1513.
130. Sridharan S., Derrick G., Deanfield J., Taylor A.M. Assessment of differential branch pulmonary blood flow: a comparative study of phase contrast magnetic resonance imaging and radionuclide lung perfusion imaging. Heart 2006, 92:963-968.
131. Nielsen J.C., Powell A.J., Gauvreau K., Marcus E.N., Prakash A., Geva T. Magnetic resonance imaging predictors of coarctation severity. Circulation 2005, 234:542-547.
132. Crean A. Cardiovascular MR and CT in congenital heart disease. Heart 2007, 93:1634-1647.
133. Taylor A.M., Dymarkowski S., Hamaekers P., Razavi R., Gewillig M., Mertens L., et al. MR coronary angiography and late-enhancement myocardial MR in children who underwent arterial switch surgery for transposition of great arteries. Radiology 2005, 234:542-547.
134. Chen S.J., Lin M.T., Lee W.J., Liu K.L., Wang J.K., Chang C.I., et al. Coronary artery anatomy in children with congenital heart disease by computed tomography. Int J Cardiol 2007, 120:363-370.
135. Pfammatter J.P., Berdat P.A., Carrel T.P., Stocker F.P. Pediatric open heart operations without diagnostic cardiac catheterization. Ann Thorac Surg 1999, 68:532-536.
136. Chowdhury U.K., Airan B., Kothari S.S., Sharma R., Subramaniam G.K., Bhan A., et al. Surgical outcome of staged univentricular-type repairs for patients with univentricular physiology and pulmonary hypertension. Indian Heart J 2004, 56:320-327.
137. Penny D.J., Shekerdemian L.S. Management of the neonate with symptomatic congenital heart disease. Arch Dis Child Fetal Neonatal Ed 2001, 84:F141-F145.
138. Finan E., Mak W., Bismilla Z., McNamara P.J. Early discontinuation of intravenous prostaglandin E1 after balloon atrial septostomy is associated with an increased risk of rebound hypoxemia. J Perinatol 2008, 28:341-346.
139. Rocchini A.P. Interventional cardiology. Pediatric Cardiac Surgery 2003, 74-99. Mosby, Philadelphia, PA. 3rd ed. C. Mavroudis (Ed.).
140. Hickey P.R., Hansen D.D., Wessel D.L., Lang P., Jonas R.A. Blunting of stress responses in the pulmonary circulation of infants by fentanyl. Anesth Analg 1985, 64:1137-1142.
141. Fackler J.C., Arnold J.H. Anesthetic principles and operating room anesthesia regimens. Pediatric Critical Care 2006, 1719-1747. Mosby, Elsevier, Philadelphia, PA. B.P. Fuhrman, J. Zimmerman (Eds.).
142. Richardson P., McKenna W., Bristow M., Maisch B., Mautner B., O'Connell J., et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996, 93:841-842.
143. Chang A., Hanley F., Wernovsky G., Wessel D.L. Pediatric Cardiac Intensive Care 1998, 492. Lippincott Williams & Wilkins, Baltimore, MD.
144. Burrows F.A., Klinck J.R., Rabinovitch M., Bohn D.J. Pulmonary hypertension in children: perioperative management. Can Anaesth Soc J 1986, 33:606-628.
145. Gassner S., Cohen M., Aygen M., Levy E., Ventura E., Shadhdi J. The effect of ketamine on pulmonary artery pressure. J Anesth 1974, 29:141-146.
146. Morray J.P., Lynn A.M., Stamm S.J., Herndon P.S., Kawabori I., Stevenson J.G. Hemodynamic effects of ketamine in children with congenital heart disease. Anesth Analg 1984, 63:895-899.
147. Hickey P.R., Hansen D.D., Cramolini G.M., Vincent R.N., Lang P. Pulmonary and systemic hemodynamic responses to ketamine in infants with normal and elevated pulmonary vascular resistance. Anesthesiology 1985, 62:287-293.
148. Wigle E.D., Rakowski H., Kimball B.P., Williams W.G. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation 1995, 92:1680-1692. [review].
149. Spirito P., Seidman C., McKenna W.J., Maron B.J. The management of hypertrophic cardiomyopathy. N Engl J Med 1997, 336:775-785. [review].
150. Maron B.J., Towbin J.A., Thiene G., Antzelevitch C., Corrado D., Arnett D., et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006, 113:1807-1816.
151. Maron B.J., McKenna W.J., Danielson G.K., Kappenberger L.J., Kuhn H.J., Seidman C.E., et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003, 42:1687-1713.
152. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002, 287:1308-1320. [review].
153. Starnes V.A., Bernstein D., Oyer P.E., Gamberg P.L., Miller J.L., Baum D., et al. Heart transplantation in children. J Heart Transplant 1989, 8:20-26.
154. Warner M.A., Lunn R.J., O'Leary P.W., Schroeder D.R. Outcomes of noncardiac surgical procedures in children and adults with congenital heart disease. Mayo Clin Proc 1998, 73:728-734.
155. Carmosino M.J., Friesen R.H., Doran A., Ivy D.D. Perioperative complications in children with pulmonary hypertension undergoing non cardiac surgery or cardiac catheterization. Anesth Analg 2007, 104:521-527.
156. Wolfe R.R., Loehr J.P., Schaffer M.S., Wiggins J.W. Hemodynamic effects of ketamine, hypoxia and hyperoxia in children with surgically treated congenital heart disease residing 1200 meters above sea level. Am J Cardiol 1991, 67:84-87.
157. Williams G.D., Jones T.K., Hanson K.A., Morray J.P. The hemodynamic effects of propofol in children with congenital heart disease. Anesth Analg 1999, 89:1411-1416.
158. Hickey P.R., Hansen D.D., Wessel D.L., Lang P., Jonas R.A. Pulmonary and systemic hemodynamic responses to fentanyl in infants. Anesth Analg 1985, 64:483-486.
159. Chanavaz C., Tirel O., Wodey E., Bansard J.Y., Senhadji L., Robert J.C., et al. Haemodynamic effects of remifentanil in children with and without intravenous atropine: an echocardiographic study. Br J Anaesth 2005, 94:74-79.
160. Blaise G., Langleben D., Hubert B. Pulmonary arterial hypertension: pathophysiology and anesthetic approach. Anesthesiology 2003, 99:1415-1432. [review].
161. van Son J.A., Edwards W.D., Danielson G.K. Pathology of coronary arteries, myocardium, and great arteries in supravalvular aortic stenosis. J Thorac Cardiovasc Surg 1994, 108:21-28.
162. Terhune P.E., Buchino J.J., Rees A.H. Myocardial infarction associated with supravalvular aortic stenosis. J Pediatr 1985, 106:251-254.
163. Conway E.E., Noonan J., Marion R.W., Steeg C.N. Myocardial infarction leading to sudden death in the Williams syndrome: report of three cases. J Pediatr 1990, 117:593-595.
164. Black J.A., Carter R.E. Association between aortic stenosis and facies of severe infantile hypercalcemia. Lancet 1963, 2:745-748.
165. Bird L.M., Billman G.F., Lacro R.V., Spicer R.L., Jariwala L.K., Hoyme H.E., et al. Sudden death in Williams syndrome: report of ten cases. J Pediatr 1996, 129:926-931.
166. Lacro R.V., Perry S.B., Keane J.F., Castenata A.R., Lock J.E. Combined transcatheter and surgical therapy for severe bilateral outflow tract obstruction in Williams syndrome and familial supravalvular aortic stenosis. Circulation 1994, 90:1-587.
167. Pansegrau D.G., Martin M.M., Kioshos J.M., Dumin R.E., Kroetz F.W. Supravalvular aortic stenosis in adults. Am J Cardiol 1973, 31:635-641.
168. Morrow A.G., Waldhausen J.A., Peters R.L., Blood-well R.D., Braunwald E. Supravalvular aortic stenosis: clinical, hemodynamic and pathologic observations. Circulation 1959, 20:1003-1010.
169. Martin M.M., Lemmer J.H., Shaffer E., Dick M., Bove E.L. Obstruction to left coronary artery blood flow secondary to obliteration of the coronary ostium in supravalvular aortic stenosis. Ann Thorac Surg 1988, 45:16-20.
170. Kahler R.L., Braunwald E., Planth W.H., Morrow A.G. Familial congenital heart disease. Am J Med 1966, 40:384-399.
171. Blieden L.C., Lucas R.V., Carter J.B., Miller K., Edwards J.E. A developmental complex including supravalvular stenosis of the aorta and pulmonary trunk. Circulation 1974, 49:585-590.
172. Sehmidt R.E., Gilbert E.F., Amend T.C., Chamberlain C.R., Lucas R.V. Generalized arterial fibromuscular dysplasia and myocardial infarction in familial supravalvular aortic stenosis syndrome. J Pediatr 1969, 74:576-584.
173. Cheu S., Fiese M.J., Hatayama E. Supra-aortic stenosis: congenital, supra-aortic valvular, stenosing membrane on the aortic cusps. Am J Clin Pathol 1957, 28:293-300.
174. Horowitz P.E., Akhtar S., Wulff J.A., Al Fadley F., Al Halees Z. Coronary artery disease and anesthesia-related death in children with Williams syndrome. J Cardiothorac Vasc Anesth 2002, 16:739-741.
175. Denie J.J., Verheugt A.P. Supravalvular aortic stenosis. Circulation 1958, 18:902-908.
176. Longnecker D.E., Tinker J.H., Morgan G.E. Principles and Practice of Anesthesiology 1998, Mosby, St. Louis, MO. 2nd ed.
177. Harmel M., Lamont A. Anesthesia in the surgical treatment of pulmonic stenosis. Anesthesiology 1946, 7:477-498.
178. Van Norman G., Jackson S.G., Waisel D. Informed consent: ethical implications in clinical practice. Curr Opin Anaesthesiol 2004, 17:177-181.
179. Morray J.P., Geiduschek J.M., Ramamoorthy C., Haberkern C.M., Hackel A., Caplan R.A., et al. Anesthesia-related cardiac arrest in children: initial findings of the Pediatric Perioperative Cardiac Arrest (POCA) Registry. Aneshesiology 2000, 93:6-14.
180. Lewis I., Burke C., Voepel-Lewis T., Tait A.R. Children who refuse anesthesia or sedation: a survey of anesthesiologists. Paediatr Anaesth 2007, 17:1134-1142.
181. Domino K.B., Bowdle T.A., Posner K.L., Spitellie P.H., Lee L.A., Cheney F.W. Injuries and liability related to central vascular catheters: a closed claims analysis. Anesthesiology 2004, 100:1411-1418.
182. Sundar S., DiNardo J.A. Transesophageal echocardiography in pediatric surgery. Int Anesthesiol Clin 2008, 46:137-155.
183. Wilson W., Taubert K.A., Gewitz M., Lockhart P.B., Baddour L.M., Levison M., et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and The Council on Clinical Cardiology, Council on Cardiovascular Surgery and anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J Am Dent Assoc 2007, 138:739-745. 747-60.
184. Mangano D.T., Tudor I.C., Dietzel C. Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006, 354:353-365.
185. Eaton M. Antifibrinolytic therapy in surgery for congenital heart disease. Anesth Analg 2008, 106:1087-1100.
186. Aronson L.A., Spaeth J.P. Frontiers in pediatric anesthesia: cardiac anesthesia. Int Anesthesiol Clin 2006, 44:33-49.
187. Andropoulos D.B., Stayer S.A., Diaz L.K., Ramamoorthy C. Neurological monitoring for congenital heart surgery. Anesth Analg 2004, 99:1365-1375.
188. Hoffman T.M., Wernovsky G., Atz A.M., Kulik T.J., Nelson D.P., Chang A.C., et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003, 107:996-1002.
189. Park K.W. Protamine and protamine reactions. Int Anesthesiol Clin 2004, 42:135-145.
190. Seifert H.A., Jobes D.R., Ten Have T., Kimmel S.E., Montenegro L.M., Steven J.M., et al. Adverse events after protamine administration following cardiopulmonary bypass in infants and children. Anesth Analg 2003, 97:383-389.
191. Hosokawa K., Shime N., Kato Y., Taniguchi A., Maeda Y., Miyazaki T., et al. Dexmedetomidine sedation in children after cardiac surgery. Pediatric Critical Care Medicine. Pediatr Crit Care Med 2010, 11:39-43.
192. Kirshbom P.M., Myung R.J., Simsic J.M., Kramer Z.B., Leong T., Kogon B.E., et al. One thousand repeat sternotomies for congenital cardiac surgery: risk factors for reentry injury. Ann Thorac Surg 2009, 88:158-161.
193. Monro L.J., Alexiou C., Salmon A.P., Keeton B.R. Reoperations and survival after primary repair of congenital heart defects in children. T Thorac Cardiovasc Surg 2003, 126:511-520.
194. Shumacker H.B. The birth of an idea and the development of cardiopulmonary bypass. Cardiopulmonary Bypass-Principles and Practice 2008, Wolters KluwerHealth-Lippincott Williams & Wilkins, Philadelphia, PA. 3rd ed. G.P. Gravlee, R.F. Davis, A.H. Stammers, R.M. Ungerleider (Eds.).
195. Lillehei C.W., Varco R.L., Cohen M., Warden H.E., Patton C., Moller J. The first open-heart repairs of ventricular septal defect, atrioventicular communis, and tetralogy of fallot using extracorporeal circulation by cross-circulation: a 30-year follow-up. Ann Thorac Surg 1986, 41:4-21.
196. Giacomuzzi C., Mejak B., Shen I. Pediatric cardiopulmonary bypass. Overview: state of the art and future. Cardiopulmonary Bypass-Principles and Practice 2008, 685-734. Wolters KluwerHealth-Lippincott Williams & Wilkins, Philadelphia, PA. 3rd ed. G.P. Gravlee, R.F. Davis, A.H. Stammers (Eds.).
197. Jones T.J., Elliot M.J. Paediatric CPD: bypass in a high risk group. Perfusion 2006, 21:229-233.
198. Groom R.C., Froebe S., Martin J., Manfra M.J., Cormack J.E., Morse C., et al. Update on pediatric perfusion practice in North America: 2005 survey. J Extra Corpor Technol 2005, 37:343-350.
199. Ungerleider R. Practice patterns in neonatal cardiopulmonary bypass. Thorac Cardiovasc Surg Pediatr Card Surg Annu 2004, 7:172-179.
200. McQuillen P.S., Barkovich A.J., Hamrick S.E., Perez M., Ward P., Glidden D.V., et al. Temporal and anatomic risk profile of brain injury with neonatal repair of congenital heart defects. Stroke 2007, 38(suppl):736-741.
201. McQuillen P.S., Hamrick S.E., Perez M.J., Barkovich A.J., Glidden D.V., Karl T.R., et al. Balloon atrial septostomy is associated with preoperative stroke in neonates with transposition of the great arteries. Circulation 2006, 113:280-285.
202. Galli K.K., Zimmerman R.A., Jarvik G.P., Wernovsky G., Kuypers M.K., Clancy R.R., et al. Periventricular leukomalacia is common after neonatal cardiac surgery. J Thorac Cardiovasc Surg 2004, 127:692-704.
203. Hoffman J.I.E., Rudolph A.M., Heymann M.A. Pulmonary vascular disease with congenital heart lesions: pathologic features and causes. Circulation 1981, 64:873-877.
204. McMullan D.M., Bekker J.M., Parry A.J., Johengen M.J., Kon A., Heidersbach R.S., et al. Alterations in endogenous nitric oxide production after cardiopulmonary bypass in lambs with normal and increased pulmonary blood flow. Circulation 2000, 102(19 suppl 3):III172-III178.
205. Mossad E., Motta P., Sehmbey K., Toscana D. The hemodynamic effects of phenoxybenzamine in neonates, infants, and children. J Clin Anesth 2008, 20:94-98.
206. Taylor K.M. Cardiopulmonary Bypass 1986, Chapman & Hall, London, United Kingdom.
207. Noris M., Morigi M., Donadelli R., Aiello S., Foppolo M., Todeschini M., et al. Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ Res 1995, 76:536-543.
208. Alkan T., Akçevin A., Undar A., TürkoǧF;lu H., Paker T., Aytaç A. Effects of pulsatile and nonpulsatile perfusion on vital organ recovery in pediatric heart surgery: a pilot clinical study. ASAIO J 2006, 52:530-535.
209. Alkan T., Akçevin A., Undar A., Türkoǧlu H., Paker T., Aytaç A. Benefits of pulsatile perfusion on vital organ recovery during and after pediatric open heart surgery. ASAIO J 2007, 53:651-654.
210. Greeley W.J., Kern F.H., Ungerleider R.M., Boyd J.L., Quill T., Smith L.R., et al. The effect of hypothermic cardiopulmonary bypass and total circulatory arrest on cerebral metabolism in neonates, infants, and children. J Thorac Cardiovasc Surg 1991, 101:783-794.
211. Rebeyka I.M., Hana S.A., Borges M.R., Lee K.F., Yeh T., Tuchy G.E., et al. Rapid cooling contracture of the myocardium. The adverse effect of prearrest cardiac hypothermia. J Thorac Cardiovasc Surg 1990, 100:240-249.
212. Kurihara S., Sakai T. Effects of rapid cooling on mechanical and electrical responses in ventricular muscle of guinea-pig. J Physiol 1985, 361:361-378.
213. Bridge J.H. Relationships between the sarcoplasmic reticulum and sarcolemmal calcium transport revealed by rapidly cooling rabbit ventricular muscle. J Gen Physiol 1986, 88:437-473.
214. Bers D.M., Bridge J.H., Spitzer K.W. Intracellular Ca 2+ transients during rapid cooling contractures in guinea-pig ventricular myocytes. J Physiol 1989, 417:537-553.
215. Williams W.G., Rebeyka I.M., Tibshirani R.J., Coles J.G., Lightfoot N.E., Mehra A., et al. Warm induction blood cardioplegia in the infant. A technique to avoid rapid cooling myocardial contracture. J Thorac Cardiovasc Surg 1990, 100:896-901.
216. Torchiana D.F., Love T.R., Hendren W.G., Geffin G.A., Titus J.S., Redonnett B.E., et al. Calcium induced ventricular contraction during cardioplegic arrest. J Thorac Cardiovasc Surg 1987, 94:606-613.
217. Cannon M.B., Vine A.J., Kantor H.L., Lahorra J.A., Nickell S.A., Hahn C., et al. Warm and cold blood cardioplegia. Comparison of myocardial function and metabolism using 31p magnetic resonance spectroscopy. Circulation 1994, 90(5 Pt. 2):II329-II338.
218. Lahorra J.A., Torchiana D.F., Tolis G., Bashour C.A., Hahn C., Titus J.S., et al. Rapid cooling contracture with cold cardioplegia. Ann Thorac Surg 1997, 63:1353-1360.
219. Aoki M., Nomure F., Kawate H., Mayer J.E. Effect of calcium and preischemic hypothermia on recovery of myocardial function after cardioplegic ischemia in neonatal lambs. J Thorac Cardiovasc Surg 1993, 105:207-212. discussion 212-3.
220. Reddy V.M., Hanley F.L. Techniques to avoid circulatory arrest in neonates undergoing repair of complex heart defects. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2001, 4:277-280.
221. Langley S.M., Chai P.J., Miller S.E., Mault J.R., Jaggers J.J., Tsui S.S., et al. Intermittent perfusion protects the brain during deep hypothermic circulatory arrest. Ann Thorac Surg 1999, 68:4-13.
222. Durandy Y.D., Younes M., Mahut B. Pediatric warm open heart surgery and prolonged cross-clamp time. Ann Thorac Surg 2008, 86:1941-1947.
223. Boldt J., Knothe C., Welters I., Dapper F., Hempelmann G. Normothermic versus hypothermic cardiopulmonary bypass: do changes in coagulation differ?. Ann Thorac Surg 1996, 62:130-135.
224. Mazer C.D., Hornstein A., Freedman J. Platelet activation in warm and cold heart surgery. Ann Thorac Surg 1996, 59:1481-1486.
225. Randomised trial of normothermic versus hypothermic coronary bypass surgery. Lancet 1994, 343:559-563. Warm Heart Investigators.
226. Birdi I., Regragui I., Izzat M.B., Bryan A.J., Angelini G.D. Influence of normothermic systemic perfusion during coronary artery bypass operations: a randomized prospective study. J Thorac Cardiovasc Surg 1997, 114:475-481.
227. Kirshbom P.M., Skaryak L.R., DiBernardo L.R., Kern F.H., Greeley W.J., Gaynor J.W. Benefits of pulsatile perfusion on vital organ recovery during and after pediatric open heart surgery. J Thorac Cardiovasc Surg 1996, 111:145-155. discussion 156-7.
228. Allen B.S. Current concepts in pediatric myocardial protection. Myocardial Protection 2004, 207-229. Futura, Blackwell, Elmsford, NY. T.A. Salerno, M. Ricci (Eds.).
229. Hammon J.W. Myocardial protection in the immature heart. Ann Thorac Surg 1995, 60:839-842.
230. Doenst T., Schlensak C., Beyersdorf F. Cardioplegia in pediatric cardiac surgery: do you believe in magic?. Ann Thorac Surg 2003, 75:1668-1677. [review].
231. Chai P.J. Myocardial protection and preservation for neonates and infants. Cardiopulmonary Bypass-Principles and Practice 2008, 700-709. Wolters KluwerHealth-Lippincott Williams & Wilkins, Philadelphia, PA. G.P. Gravlee, R.F. Davis, A.H. Stammers, R.M. Ungerleider (Eds.).
232. Bittira B., Shum-Tim D., Tchervenkov C.I. New concepts in myocardial protection in pediatric cardiac surgery. Myocardial Protection 2004, 264-274. Futura, Blackwell, Elmsford, NY. T.A. Salerno, M. Ricci (Eds.).
233. Lopaschuk G.D., Collins-Nakai R.L., Itoi T. Developmental changes in energy substrate use by the heart. Cardiovasc Res 1992, 26:1172-1180.
234. Kodde I.F., van der Stok J., Smolenski R.T., de Jong J.W. Metabolic and genetic regulation of cardiac energy substrate preference. Comp Biochem Physiol A Mol Integr Physiol 2007, 146:26-39.
235. Jung D.H., Lee C.J., Suh C.K., You H.J., Kim D.H. Molecular properties of excitation-contraction coupling proteins in infant and adult human heart tissues. Mol Cells 2005, 20:51-56.
236. Grice W.N., Konishi T., Apstein C.S. Resistance of neonatal myocardium to injury during normothermic and hypothermic ischemic arrest and reperfusion. Circulation 1987, 76(suppl 5):150.
237. Bove E.L., Gallagher K.P., Drake D.H. The effect of hypothermic ischemia on recovery of left ventricular function and preload reserve in the neonatal heart. J Thorac Cardiovasc Surg 1988, 95:814-818.
238. Bull C., Cooper J., Stark J. Cardioplegic protection of the child's heart. J Thorac Cardiovasc Surg 1988, 95:223-229.
239. Lupinetti F.M., Wareing T.H., Huddleston C.B., Collins J.C., Boucek R.J., Bender H.W., et al. Pathophysiology of chronic cyanosis in a canine model: functional and metabolic response to global ischemia. J Thorac Cardiovasc Surg 1985, 90:291-296.
240. del Nido P.J., Mickle D.A., Wilson G.J., Benson L.N., Weisel R.D., Coles J.G., et al. Inadequate myocardial protection with cold cardioplegic arrest during repair of tetralogy of Fallot. J Thorac Cardiovasc Surg 1988, 95:223-229.
241. Graham T.P., Erath H.G., Buckspan G.S., Fisher R.D. Myocardial anaerobic metabolism during isoprenaline infusion in a cyanotic animal model: possible cause of myocardial dysfunction in cyanotic congenital heart disease. Cardiovasc Res 1979, 13:401-406.
242. Buckberg G.D., Allen B.S. Myocardial protection management during adult cardiac operations. Glenn's Thoracic and Cardiovascular Surgery 1995, 1653-1687. Appleton and Lange, East Norwalk, CT. A.E. Baue, A.S. Geha, G.L. Hammond (Eds.).
243. Bolling K.S., Kronon M., Allen B.S., Ramon S., Wang T., Hartz R.S., et al. Myocardial protection in normal and hypoxically stressed neonatal hearts: the superiority of blood versus crystalloid cardioplegia. J Thorac Cardiovasc Surg 1997, 113:994-1005.
244. Modi P., Suleiman M.S., Reeves B., Pawade A., Parry A.J., Angelini G.D., et al. Myocardial metabolic changes during pediatric cardiac surgery: a randomized study of 3 cardioplegic techniques. J Thorac Cardiovasc Surg 2004, 128:67-75.
245. Lareau S., Boyle A.J., Stewart L.C., Deslauriers R., Hendry P., Keon W.J., et al. The role of magnesium in myocardial preservation. Magnes Res 1995, 8:85-97.
246. Kronon M.I., Allen B.S., Hernan J., Halldorsson A.O., Rahman S., Buckberg G.D., et al. Superiority of magnesium cardioplegia in neonatal myocardial protection. Ann Thorac Surg 1999, 68:2285-2291. discussion 2291-2.
247. Kronon M., Allen B.S., Bolling K.S., Rahman S., Wang T., Maniar H.S., et al. The role of cardioplegic induction temperature and amino acid enrichment in neonatal myocardial protection. Ann Thorac Surg 2003, 3:756-764.
248. Allen B.S. Pediatric myocardial protection: a cardioplegic strategy is the "solution". Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2004, 7:141-154.
249. Follette D., Fey K., Buckberg G.D., Helly J.J., Steed D.L., Foglia R.P., et al. Reducing post-ischemic damage by temporary modifications of reperfusate calcium, potassium, pH, and osmolarity. J Thorac Cardiovasc Surg 1981, 82:221-238.
250. Allen B.S., Okamoto F., Buckberg G.D., Bugyi H., Young H., Leaf J., et al. Studies of controlled perfusion after ischemia: immediate functional recovery after 6 hours of regional ischemia by careful control of conditions of reperfusion and composition of reperfusate. J Thorac Cardiovasc Surg 1986, 92:621-663.
251. Teoh K.H., Christiakis G.T., Weisel R.D., Fremes S.E., Mickle D.A., Romaschin A.D., et al. Accelerated myocardial metabolic recovery with terminal warm blood cardioplegia. J Thorac Cardiovasc Surg 1986, 91:888-895.
252. Kirklin J., Barrat-Boyes B. Myocardial management during cardiac surgery with cardiopulmonary bypass. Cardiac Surgery 1993, Churchill-Livingstone, New-York, NY. J. Kirklin, B. Barrat-Boyes (Eds.).
253. Kronon M., Allen B.S., Rahman S., Wang T., Tayyab N.A., Bolling K.S., et al. Reducing post ischemic reperfusion damage in neonates using a terminal warm substrate enriched blood cardioplegic reperfusate. Ann Thorac Surg 2000, 70:765-770.
254. Toyoda Y., Yamaguchi M., Yoshimura N., Oka S., Okita Y. Cardioprotective effects and the mechanisms of terminal warm blood cardioplegia in pediatric cardiac surgery. J Thorac Cardiovasc Surg 2003, 125:1241-1251.
255. Taggart D.P., Hadjinikolas L., Hooper J., Albert J., Kemp M., Hue D., et al. Effects of age and ischemic times on biochemical evidence of myocardial injury after pediatric cardiac operations. J Thorac Cardiovasc Surg 1997, 113:728-735.
256. Buckberg G.D., Allen B.S., Beyersdorf F. Blood cardioplegic strategies during adult cardiac operations. Ischemia-Reperfusion in Cardiac Surgery 1993, 181-227. Kluwer Academic, Dordrecht, Netherlands. H.M. Piper, C.J. Preusse (Eds.).
257. Buckberg G.D., Beyersdorf F., Allen B.S. Integrated myocardial management: background and initial application. J Cardiovasc Surg 1995, 10:68-89.
258. Rosenkranz E.R., Feng J., Li H.L. Myocardial preconditioning in the experimental model: a new strategy to improve myocardial protection. Myocardial Protection 2004, 230-263. Futura, Blackwell, Elmsford, NY. T.A. Salerno, M. Ricci (Eds.).
259. Cheung M.M., Kharbanda R.K., Konstantinov I.E., Shimizu M., Frndova H., Li J., et al. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery. J Am Coll Cardiol 2006, 47:2277-2282.
260. Elliott M.J. Ultrafiltration and modified ultrafiltration in pediatric open-heart operations. Ann Thorac Surg 1993, 56:1518-1522. [review].
261. Ungerleider R.M. Effects of cardiopulmonary bypass and use of modified ultrafiltration. Ann Thorac Surg 1998, 65(suppl):S35-S39. discussion S39, S74-6.
262. Millar A.B., Armstrong L., van der Linden J. Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass. Ann Thorac Surg 1993, 56:1499-1502.
263. Zahler S., Massoudy P., Hartl H., Hähnel C., Meisner H., Becker B.F. Acute cardiac inflammatory responses to postischemic reperfusion during cardiopulmonary bypass. Cardiovasc Res 1999, 41:722-730.
264. Rinder C.S., Bonan J.L., Rinder H.M., Mathew J., Hines R., Smith B.R. Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood 1992, 79:1201-1205.
265. Moat N.E., Shore D.F., Evans T.W. Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins. Eur J Cardio Thorac Surg 1993, 7:563-573. [review].
266. Kirklin J.K., Westaby S., Blackstone E.H., Kirklin J.W., Chenoweth D.E., Pacifico A.D. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983, 86:845-857.
267. Oudemans-van Straaten H.M., Jansen P.G., Hoek F.J., van Deventer S.J., Sturk A., Stoutenbeek C.P., et al. Intestinal permeability, circulating endotoxin, and postoperative systemic responses in cardiac surgery patients. J Cardiothorac Vasc Anesth 1996, 10:187-194.
268. Madhok A.B., Ojamaa K., Haridas V., Parnell V.A., Pahwa S., Chowdhury D. Cytokine response in children undergoing surgery for congenital heart disease. Pediatr Cardiol 2006, 27:408-413.
269. Cremer J., Martin M., Redl H., Bahrami S., Abraham C., Graeter T., et al. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 1996, 61:1714-1720.
270. Seghaye M.C., Duchateau J., Grabitz R.G., Faymonville M.L., Messmer B.J., Buro-Rathsmann K., et al. Complement activation during cardiopulmonary bypass in infants and children: relation to postoperative multiple system organ failure. J Thorac Cardiovasc Surg 1993, 106:978-987.
271. Holmes J.H., Connolly N.C., Paull D.L., Hill M.E., Guyton S.W., Ziegler S.F., et al. Magnitude of the inflammatory response to cardiopulmonary bypass and its relation to adverse clinical outcomes. Inflamm Res 2002, 51:579-586.
272. Pavelková M., Kubala L., Cíz M., Pavlík P., Wagner R., Slavík J., et al. Blood phagocyte activation during open heart surgery with cardiopulmonary bypass. Physiol Res 2006, 55:165-173.
273. Paparella D., Yau T.M., Youngg E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment: an update. Eur J Cardio Thorac Surg 2002, 21:232-244.
274. Naik S.K., Knight A., Elliott M. A prospective randomized study of a modified technique of ultrafiltration during pediatric open-heart surgery. Circulation 1991, 84(suppl):III422-III431.
275. Schroeder V.A., Pearl J.M., Schwartz S.M., Shanley T.P., Manning P.B., Nelson D.P. Combined steroid treatment for congenital heart surgery improves oxygen delivery and reduces postbypass mediator expression. Circulation 2003, 107:2823-2828.
276. Tassani P., Richter J.A., Barankay A., Braun S.L., Haehnel C., Spaeth P., et al. Does high-dose methylprednisolone in aprotinin-treated patients attenuate the systemic inflammatory response during coronary artery bypass grafting procedures?. J Cardiothorac Vasc Anesth 1999, 13:165-172.
277. Hoffman T.M., Wernovsky G., Atz A.M., Bailey J.M., Akbary A., Kocsis J.F., et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics. Am Heart J 2002, 143:15-21.
278. Guibourdenche M., Høiby E.A., Riou J.Y., Varaine F., Joguet C., Caugant D.A. Epidemics of serogroup A Neisseria meningitidis of subgroup III in Africa, 1989-94. Epidemiol Infect 1996, 116:115-120.
279. Mayumi H., Zhang Q.W., Nakashima A., Masuda M., Kohno H., Kawachi Y., et al. Synergistic immunosuppression caused by high-dose methylprednisolone and cardiopulmonary bypass. Ann Thorac Surg 1997, 63:129-137.
280. Checchia P.A., Backer C.L., Bronicki R.A., Baden H.P., Crawford S.E., Green T.P., et al. Dexamethasone reduces postoperative troponin levels in children undergoing cardiopulmonary bypass. Crit Care Med 2003, 31:1742-1745.
281. Giomarelli P., Scolletta S., Borrelli E., Biagioli B. Myocardial and lung injury after cardiopulmonary bypass: role of interleukin (IL)-10. Ann Thorac Surg 2003, 77:117-123.
282. Pearl J.M., Schwartz S.M., Nelson D.P., Wagner C.J., Lyons J.M., Bauer S.M., et al. Preoperative glucocorticoids decrease pulmonary hypertension in piglets after cardiopulmonary bypass and circulatory arrest. Ann Thorac Surg 2004, 77:994-1000.
283. Kilger E., Weis F., Briegel J., Frey L., Goetz A.E., Reuter D., et al. Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med 2003, 31:1068-1074.
284. Schroeder V.A., Pearl J.M., Schwartz S.M., Shanley T.P., Manning P.B., Nelson D.P. Combined steroid treatment for congenital heart surgery improves oxygen delivery and reduces post bypass mediator expression. Circulation 2003, 107:2823-2828.
285. Chaney M.A., Nikolov M.P., Blakeman P., Bakhos M., Slogoff S. Hemodynamic effects of methylprednisolone in patients undergoing cardiac operation and early extubation. Ann Thorac Surg 1999, 67:1006-1011.
286. Chaney M.A., Nikolov M.P., Blakeman B., Bakhos M., Slogoff S. Pulmonary effects of methylprednisolone in patients undergoing coronary artery bypass grafting and early tracheal extubation. Anesth Analg 1998, 87:27-33.
287. Checchia P.A., Bronicki R.A., Costello J.M., Nelson D.P. Steroid use before pediatric cardiac operations using cardiopulmonary bypass: an international survey of 36 centers. Pediatr Crit Care Med 2005, 6:441-444.
288. Wan S., DeSmet J.M., Barvais L., Goldstein M., Vincent J.L., LeClerc J.L. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996, 112:806-811.
289. Shum-Tim D., Tchervenkov C.I., Laliberté E., Jamal A.M., Nimeh T., Luo C.Y., et al. Timing of steroid treatment is important for cerebral protection during cardiopulmonary bypass and circulatory arrest: minimal protection of pump prime methylprednisolone. Eur J Cardio Thorac Surg 2003, 24:125-132.
290. Lodge A.J., Chai P.J., Daggett C.W., Ungerleider R.M., Jaggers J. Methylprednisolone reduces the inflammatory response to cardiopulmonary bypass in neonatal piglets: timing of dose is important. J Thorac Cardiovasc Surg 1999, 117:515-522.